Ico Therapeutics (ICOTF) 0.0400 $ICOTF iCo Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2016 at 7:03 AM

Ico Therapeutics (ICOTF) 0.0400 $ICOTF

iCo Therapeutics Announces First Quarter 2016 Financial Results
CNW Group - Wed May 25, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended March 31, 2016. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"

.
ICO.VN: 0.055 (unch)

iCo Therapeutics Announces Year End 2015 Financial Results
CNW Group - Thu Apr 14, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the year ended December 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"

.
ICO.VN: 0.055 (unch)

iCo Strategic Reorganization
CNW Group - Mon Jan 18, 6:00AM CST
iCo Therapeutics Inc. ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today announced that effective immediately, in an effort to preserve its asset base and maximize shareholder value, the company is undertaking a strategic re-organization.
ICO.VN: 0.055 (unch)

iCo Therapeutics Announces Changes to Board of Directors
CNW Group - Thu Dec 24, 6:00AM CST
iCo Therapeutics Inc. ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today announced the appointment of Susan Koppy and John Meekison to iCo's Board of Directors.
ICO.VN: 0.055 (unch), NVS: 81.06 (+1.12)

/C O R R E C T I O N from Source -- iCo Therapeutics Inc./
PR Newswire - Tue Nov 24, 6:21PM CST
In the news release, iCo Therapeutics Announces Third Quarter 2015 Financial Results, issued today by iCo Therapeutics Inc. over CNW, we are advised by the company that in the paragraph Summary Third Quarter 2015 Results, the last sentence should have read "Immune Pharmaceuticals Inc.", rather than "Immune Therapeutics Inc." as originally issued inadvertently. The complete, corrected release follows:
ICO.VN: 0.055 (unch), IMNP: 0.29 (-0.02)

iCo Therapeutics Announces Third Quarter 2015 Financial Results
CNW Group - Tue Nov 24, 4:00PM CST
iCo Therapeutics ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended September 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"

.
ICO.VN: 0.055 (unch)

iCo Therapeutics Announces Manufacturing Update for Oral Amp B Program
CNW Group - Mon Oct 26, 7:00AM CDT
iCo Therapeutics Inc. ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF) today announced that the company has engaged Corealis Pharma Inc. ("Corealis"

a contract manufacturing organization, for analytical development, formulation optimization and scale-up of the amphotericin B oral delivery system. The preparation and regulatory filings for this program are expected to be completed in 2016, with Phase 1A study data available in 2017.
ICO.VN: 0.055 (unch)

iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders
PR Newswire - Fri Jun 26, 3:00PM CDT
iCo Therapeutics ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today announced that all nominees listed in the management information circular dated June 1, 2015 were elected as directors at its 2015 Annual Meeting of Shareholders, held earlier today, June 26 2015. On a vote by ballot, the following 5 nominees proposed by management were elected as Directors of iCo Therapeutics to serve until the Company's next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favour of individual nominees as follows:
ICO.VN: 0.055 (unch)

Immune Pharmaceuticals Inc. (Nasdaq: IMNP) to Ring The Nasdaq Stock Market Closing Bell
GlobeNewswire - Fri May 22, 9:00AM CDT
What:
IMNP: 0.29 (-0.02), NDAQ: 69.62 (-0.18)

Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee
PR Newswire - Tue Apr 21, 7:30AM CDT
Immune Pharmaceuticals Inc., or "Immune" (NASDAQ: IMNP) announced that its Board of Directors has elected Rene-Pierre Azria as a Director and the Chair of the Transaction and Pricing Committee, with oversight on strategic and financial transactions. Mr. Azria will also be a member of the Audit Committee, the Compensation Committee and the Corporate Governance and Nomination Committee.
ICO.VN: 0.055 (unch), IMNP: 0.29 (-0.02)

Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet
PR Newswire - Mon Mar 16, 3:15PM CDT
Immune Pharmaceuticals Inc. ("Immune", the "Company"

(NASDAQ: IMNP) announced today that it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to license certain of Yissum's patents in order to facilitate the development of a topical nanoparticle formulation of Immune's neuropathic pain drug, AmiKet(TM).
ICO.VN: 0.055 (unch), IMNP: 0.29 (-0.02)

CEO Dr. Daniel Teper of Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) to Be Interviewed Live on Clear Channel - iHeart Business Talk Radio - December 9, 2014
Marketwired - Tue Dec 09, 10:13AM CST
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP), a company that applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer, announced today that CEO Daniel Teper will be interviewed live tomorrow by host Michael Yorba on Clear Channel - iHeart Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Mr. Teper will discuss the company's lead product candidate, Bertilimumab, which is in clinical development for moderate to severe ulcerative colitis and crohn's disease as well as bullous pemphigoid, an orphan auto-immune dermatological condition. We encourage investors, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
IMNP: 0.29 (-0.02)

iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update
PR Newswire - Fri Nov 28, 4:00PM CST
iCo Therapeutics ("iCo" or "the Company"

(TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the nine months ended September 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"

.
ICO.VN: 0.055 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Denver's Holiday Extravaganza: Lights, Markets, and More!

Stepping into Denver's Holiday Magic The holiday spirit descends upon Denver like clockwork each year, and 2026 is no exception—a short drive or flight drops you into a winter wonderland packed with more lights, markets, and cheer than you can shake a sleigh bell at. Visitors and locals alike have a smorgasbord of options to revel in. The Mile High Tree and Drone Shows:...

Quandary Peak Research Expands Litigation Expertise

Meola's Strategic Move to Quandary Peak Some folks got a knack for solving more than just ordinary puzzles, and Matthew Meola happens to be one of them. This guy's spent 13 years knee-deep in litigation consulting, wrangling with the big boys over patent, software copyright, and trade secret disputes. Now, he's teamed up with Quandary Peak Research, and it's not just any...

Lake Victoria Gold Kicks Off Imwelo Drilling Program

Drill Bit Meets Tanzanian Rock: Lake Victoria's Next Move It's not every day you hear about a company plunging rotary bits into African soil with as much gusto as Lake Victoria Gold, eh? The folks over at LVG have decided it's time to hit the ground—or rather, dig into it—with an ambitious 6,500-meter grade control drilling program at their Imwelo Gold Project in...

Lean Focus Expands: Bridging Global Expertise in APAC

A New Era for Lean Focus in the Asia Pacific The wave of business dynamics in APAC just got a little more intense. Lean Focus has thrown its hat in the ring, expanding into the Asia Pacific—a move that could shift how businesses operate in this bustling region. Forget the corporate hype for a moment and think about what this really means: local expertise, hands-on...

Caracal's Bold Branding Refresh Fuels Business Growth

A New Chapter for Caracal You ever see a company pulling off a major facelift like it's no big deal? That's exactly how Caracal Products & Services is strutting down the runway. Dubbed a leader in health care solutions, recycling, and spitting out a mix of products across the spectrum, Caracal's hitting the reset button on their brand identities. It's like watching a...

Eagle Bank Club Breathing New Life Into Historic Site

Preserving History with Contemporary Flair Sometimes, a building is more than just bricks and mortar, it's the heart of a community's memories. Come spring 2027, Eagle Bank Club is set to throw open its doors, reviving the century-old tradition of gathering in a place that's been etched into the town's identity. Scott Slater and Todd Ketlinski aren't just opening another...

Regen™ Yarn Takes Stage in Charity Race Events

Running for Charity, Clothed in Sustainability In the bustling streets of Seoul, they say charity begins at home, but it's picking up pace on the streets too. Just last week, runners in the Save Race 2026 charity event found themselves not just racing for a cause but wearing one too. Hyosung TNC, renowned for pushing eco-friendly textiles, stepped up with their recycled...

Lawyers Juggle AI's Promise and Perils in 2026

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

Spain's Young Entrepreneurs Get a Boost from Temu

Paving New Paths for Spanish Startups Temu and CEAJE are shaking hands to jumpstart a new era for Spanish entrepreneurs, promising to flip the script on digital growth and international outreach. This partnership is a big deal, aiming to leverage both parties' strengths to provide young business owners across Spain with the tools they need to ride the digital wave. A...

Flex LNG's Q3 2026: Steering Through Market Dynamics

Earnings Snapshot: Navigating Through a Challenging Quarter Ah, the quarterly earnings lottery. From the Bermuda docks, Flex LNG has thrown its hat in the ring for Q3 2026, with the game called at $97.4 million in vessel operating revenues. That's a cool $9.4 million shy of last quarter's performance. CEO Marius Foss and his crew are feeling the pressure of narrowing...